Compound 2287
Identifiers
- Canonical SMILES:
CCC(N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1)c1cccnc1
- IUPAC name:
2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxo-1-[1-(pyridin-3-yl)propyl]piperidin-3-yl]acetic acid
- InChi:
InChI=1S/C28H28Cl2N2O3/c1-3-24(20-7-5-13-31-17-20)32-26(18-9-11-21(29)12-10-18)23(19-6-4-8-22(30)14-19)15-28(2,27(32)35)16-25(33)34/h4-14,17,23-24,26H,3,15-16H2,1-2H3,(H,33,34)/t23-,24?,26-,28-/m1/s1
- InChiKey:
FYBDUDQVIFLRNC-PDVAZQOOSA-N
External links
![]() 168317832 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 1 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| MDM2-Like / P53 | 7.82 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 510.15 g/mol | |||
| HBA | 5 | |||
| HBD | 1 | |||
| HBA + HBD | 6 | |||
| AlogP | 5.35 | |||
| TPSA | 73.33 | |||
| RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 1 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| 10.1021/ml500142b | 9 | MDM2 Q00987 |
P53 P04637 |
Biochemical assay | HTRF | pIC50 (half maximal inhibitory concentration, -log10) | 7.82 | |
| 10.1021/ml500142b | 9 | MDM2 Q00987 |
P53 P04637 |
Cellular assay | EdU Cell Proliferation Assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.01 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.6522 | AMG-232 | DB15299 | |
| 0.6224 | [4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE | DB04764 | |
| 0.5882 | Nicofetamide | DB13531 | |
| 0.5786 | ABC-294640 | DB12764 | |
| 0.5705 | N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide | DB07619 | |
| 0.5685 | Osanetant | DB04872 | |
| 0.5569 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
| 0.5537 | Indinavir | DB00224 | |
| 0.5522 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | DB04724 | |
| 0.5375 | Golotimod | DB05475 | |
| 0.5359 | Abarelix | DB00106 | |
| 0.5311 | Teverelix | DB05624 | |
| 0.5305 | Oglufanide | DB05779 | |
| 0.5294 | BQ-123 | DB12054 | |
| 0.5251 | Acyline | DB11906 |




